Glucosamine + Chondroitin

What the evidence says

Glucosamine and chondroitin are cartilage constituents sold alone or together, but supplement formulations are not equivalent to standardized pharmaceutical-grade products used in some European trials. This product variability helps explain why guidelines and pooled results disagree.^[1][5]

The NIH-funded GAIT trial found the combination did not significantly reduce knee pain in the overall group versus placebo, although an exploratory moderate-to-severe-pain subgroup appeared to benefit. Subgroup results were not the primary conclusion and need cautious interpretation.^[2]

A placebo-controlled meta-analysis found small pain reductions for glucosamine or chondroitin alone but no significant pain or WOMAC benefit from their combination. A newer review likewise reported no significant symptom improvement from the combination, despite possible signals for individual standardized ingredients.^[3][4]

The American College of Rheumatology and Arthritis Foundation strongly recommend against glucosamine, alone or with chondroitin, for knee osteoarthritis, while other organizations are more permissive about selected pharmaceutical-grade preparations. NCCIH therefore concludes that meaningful symptom or structural benefit remains uncertain.^[5][1]

Most trial participants tolerate these products, but nausea, diarrhea, constipation, or headache can occur. Both supplements may increase bleeding risk with warfarin; glucosamine may alter glucose in some people, and pregnancy or breastfeeding safety is poorly established.^[1][2]